EUVIMEDEUVIMED entdecken
Crossref

Long-term clinical outcome of a weekly 2-chlorodeoxyadenosine regimen in treatment-naïve patients with hairy cell leukemia

Ye Eun Oh, Gi-June Min, Young-Woo Jeon, Tong Yoon Kim, Byung-Su Kim, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim und 4 weitere

Annals of Hematology · 2025

DOI: 10.1007/s00277-024-06173-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Ye Eun Oh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Yeouido St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, 10, 63-ro, Yeongdeungpo-gu, …. Hauptthemen laut MEDLINE: Leukemia, Hairy Cell, Cladribine. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hairy cell leukemia (HCL) has a favorable clinical outcome with appropriate treatment; however, further research is needed on managing patients with relapsed or refractory disease and the risk of infection during prolonged periods. This study examined the long-term effects of 2-chlorodeoxyadenosine (2-CdA), particularly using a weekly infusion protocol, in treatment-naïve patients with HCL. This retrospective study evaluated the long-term follow-up data from 21 South Korean patients diagnosed with HCL. Among them, 20 patients were treated with a weekly infusion protocol (0.14 mg/kg/day over 5-6 weeks), whereas one received daily continuous intravenous infusion (0.1 mg/kg/day over 7 days). The median age and follow-up period of the patients were 50 (range, 32-77) years and 39.0 (range, 7.3-223.3) months, respectively. None of the patients with HCL died from 2-CdA-related toxicity. One patient preferred a daily treatment schedule for shorter durations, and this patient required prolonged hospital stay due to an anal abscess. The overall survival (OS) was 85.7% (95% confidence interval [CI], 33.4-97.9), without reaching the median OS. The progression-free survival (PFS) was 31.3% (95% CI, 5.6-62.3), with a median PFS of 66.5 months. Among the 19 patients who achieved remission, 5 relapsed (26.3%), with a median cumulative incidence of relapse of 116.7 months. The non-relapsed mortality rate was 13.6% (95% CI, 0.4-49.1). Weekly 2-CdA provides enhanced flexibility in clinical practice, with excellent long-term OS and PFS rates, making it a valuable treatment option for patients with HCL in an outpatient setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Hairy CellCladribineHumansMiddle AgedMaleFemaleAgedAdultRetrospective StudiesFollow-Up StudiesTreatment OutcomeDrug Administration ScheduleSurvival Rate

Stichwörter der Autor:innen

2-chlorodeoxyadenosineHairy cell leukemiaInduction therapySalvage therapyTreatment outcomes

Substanzen

Cladribine

Autor:innen und Institutionen

  • Department of Hematology, Yeouido St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, 10, 63-ro, Yeongdeungpo-gu, Seoul, South Korea.
  • Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Banpo-daero 222, Seocho-Gu, Seoul, South Korea. beichest@catholic.ac.kr.
  • Department of Hematology, Eunpyeong St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, 1021, Tongil Ro, Eunpyeong-gu, Seoul, South Korea.
  • Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Banpo-daero 222, Seocho-Gu, Seoul, South Korea.

Förderung

  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Oh, Y. E., Min, G. J., Jeon, Y. W., Kim, T. Y., Kim, B. S., Park, S. S., Park, S., Yoon, J. H., Lee, S. E., Cho, B. S., Eom, K. S., Kim, Y. J., Lee, S., Kim, H. J., Min, C. K., & Cho, S. G. (2025). Long-term clinical outcome of a weekly 2-chlorodeoxyadenosine regimen in treatment-naïve patients with hairy cell leukemia. Annals of Hematology. https://doi.org/10.1007/s00277-024-06173-1

Vancouver

Oh YE, Min GJ, Jeon YW, Kim TY, Kim BS, Park SS, et al. Long-term clinical outcome of a weekly 2-chlorodeoxyadenosine regimen in treatment-naïve patients with hairy cell leukemia. Annals of Hematology. 2025. doi:10.1007/s00277-024-06173-1

BibTeX
@article{Oh2025,
  author = {Oh, Ye Eun and Min, Gi-June and Jeon, Young-Woo and Kim, Tong Yoon and Kim, Byung-Su and Park, Sung-Soo and Park, Silvia and Yoon, Jae-Ho and Lee, Sung-Eun and Cho, Byung-Sik and Eom, Ki-Seong and Kim, Yoo-Jin and Lee, Seok and Kim, Hee-Je and Min, Chang-Ki and Cho, Seok-Goo},
  title = {Long-term clinical outcome of a weekly 2-chlorodeoxyadenosine regimen in treatment-naïve patients with hairy cell leukemia},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-024-06173-1}
}
Kostenlos starten →